JPH05271276A - 環式ｈｉｖ主要中和抗原決定基及びリポペプチドを含有する合成ペプチド - Google Patents

環式ｈｉｖ主要中和抗原決定基及びリポペプチドを含有する合成ペプチド

Info

Publication number
JPH05271276A
JPH05271276A JP4334730A JP33473092A JPH05271276A JP H05271276 A JPH05271276 A JP H05271276A JP 4334730 A JP4334730 A JP 4334730A JP 33473092 A JP33473092 A JP 33473092A JP H05271276 A JPH05271276 A JP H05271276A
Authority
JP
Japan
Prior art keywords
ile
seq
amino acid
sequence
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4334730A
Other languages
English (en)
Japanese (ja)
Inventor
Richard L Tolman
リチヤード・エル・トルマン
John Hannah
ジヨン・ハンナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPH05271276A publication Critical patent/JPH05271276A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP4334730A 1991-12-18 1992-12-15 環式ｈｉｖ主要中和抗原決定基及びリポペプチドを含有する合成ペプチド Pending JPH05271276A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81104791A 1991-12-18 1991-12-18
US811047 1991-12-18

Publications (1)

Publication Number Publication Date
JPH05271276A true JPH05271276A (ja) 1993-10-19

Family

ID=25205398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4334730A Pending JPH05271276A (ja) 1991-12-18 1992-12-15 環式ｈｉｖ主要中和抗原決定基及びリポペプチドを含有する合成ペプチド

Country Status (3)

Country Link
EP (1) EP0547681A2 (enExample)
JP (1) JPH05271276A (enExample)
CA (1) CA2085083A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013527142A (ja) * 2010-03-23 2013-06-27 アイアールエム・リミテッド・ライアビリティ・カンパニー 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431327A1 (de) * 1989-11-10 1991-06-12 Hoechst Aktiengesellschaft Synthetische Vakzine zur spezifischen Induktion zytotoxischer T-Lymphozyten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2670787B1 (fr) * 1990-12-18 1995-06-23 Pasteur Institut Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431327A1 (de) * 1989-11-10 1991-06-12 Hoechst Aktiengesellschaft Synthetische Vakzine zur spezifischen Induktion zytotoxischer T-Lymphozyten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013527142A (ja) * 2010-03-23 2013-06-27 アイアールエム・リミテッド・ライアビリティ・カンパニー 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物

Also Published As

Publication number Publication date
EP0547681A3 (enExample) 1994-03-02
EP0547681A2 (en) 1993-06-23
CA2085083A1 (en) 1993-06-19

Similar Documents

Publication Publication Date Title
RU2201421C2 (ru) Синтетический пептид hiv (варианты), иммуногенная композиция для индукции иммунного ответа против пептидов hiv, диагностический набор для определения hiv-специфичных антител
Defoort et al. Macromolecular assemblage in the design of a synthetic AIDS vaccine.
US5580563A (en) Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US7311916B2 (en) Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41
AU570929B2 (en) Broad spectrum influenza antisera
IE912558A1 (en) Coconjugate vaccines comprising immunogenic protein, hiv¹related peptides, and anionic moieties
RU2337922C9 (ru) ИЗОЛИРОВАННЫЕ ПОЛИПЕПТИДЫ НА ОСНОВЕ НЕЙТРАЛИЗУЮЩЕГО ЭПИТОПА БЕЛКА p17 ВИРУСА ВИЧ, ИСПОЛЬЗУЕМЫЕ В КАЧЕСТВЕ ВАКЦИН, А ТАКЖЕ НЕЙТРАЛИЗУЮЩИЕ АНТИ-p17-АНТИТЕЛА, СПЕЦИФИЧЕСКИ РАСПОЗНАЮЩИЕ УКАЗАННЫЙ НЕЙТРАЛИЗУЮЩИЙ ЭПИТОП
AU631894B2 (en) Conjugate immunogen for aids
GB2282813A (en) Annular antigen scaffolds comprising thioether linkages
JPH05306299A (ja) ナイセリア・メニンギチジスの外膜のクラスｉｉ蛋白質とｈｉｖ−１関連ペプチドとの連結複合体、およびそれを含むワクチン
AU733234B2 (en) Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
JPH05271276A (ja) 環式ｈｉｖ主要中和抗原決定基及びリポペプチドを含有する合成ペプチド
EP0467701A2 (en) Cyclic HIV principal neutralizing determinant peptides
CN114053400B (zh) 一种预防新型冠状病毒肺炎covid-19的疫苗及其制备方法
CN114057846B (zh) 一种预防新型冠状病毒感染covid-19的多肽、免疫原性偶联物及其用途
CN114057851B (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
CN114057848B (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
KR100348183B1 (ko) 텐덤합성hiv-1펩티드들
EP0547689A2 (en) Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope
EP0551689A2 (en) Cyclic HIV principal neutralizing determinant (PNP) peptides
CN114057844A (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
CN114057849A (zh) 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
ZA200106535B (en) Methods of eliciting broadly neutralizing antibodies targeting HIV-1 GP41.